Exploring multiple myeloma survivor interest in lifestyle interventions.

Allen Hodge; Alexis Williams; Anita D'Souza; Patricia M. Sheean; Parameswaran Hari; Binod Dhakal; Kathryn E Flynn; Melinda Stolley

doi:10.1200/JCO.2020.38.15_SUPPL.E20558

Exploring multiple myeloma survivor interest in lifestyle interventions.

Allen Hodge, Alexis Williams, Anita D'Souza, Patricia M. Sheean, Parameswaran Hari, Binod Dhakal, Kathryn E Flynn, Melinda Stolley

Marcella Niehoff School of Nursing

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	38
DOIs	https://doi.org/10.1200/JCO.2020.38.15_SUPPL.E20558
State	Published - May 25 2020

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1200/JCO.2020.38.15_SUPPL.E20558License: Unspecified

Cite this

@article{045064f7f6c248c5a07bf17337bf60bc,

title = "Exploring multiple myeloma survivor interest in lifestyle interventions.",

author = "Allen Hodge and Alexis Williams and Anita D'Souza and Sheean, \{Patricia M.\} and Parameswaran Hari and Binod Dhakal and Flynn, \{Kathryn E\} and Melinda Stolley",

note = "e20558 Background: Multiple Myeloma (MM) is the second most common hematological malignancy in the U.S., with higher rates observed in older adults and African Americans (AA). Given treatment advances, most individuals survive at least 5-10 years, making symptom management important. Many survivors struggle with pain, fatigue and limited physical function, all of which may be improved through lifestyle changes.",

year = "2020",

month = may,

day = "25",

doi = "10.1200/JCO.2020.38.15\_SUPPL.E20558",

language = "American English",

volume = "38",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Exploring multiple myeloma survivor interest in lifestyle interventions.

AU - Hodge, Allen

AU - Williams, Alexis

AU - D'Souza, Anita

AU - Sheean, Patricia M.

AU - Hari, Parameswaran

AU - Dhakal, Binod

AU - Flynn, Kathryn E

AU - Stolley, Melinda

N1 - e20558 Background: Multiple Myeloma (MM) is the second most common hematological malignancy in the U.S., with higher rates observed in older adults and African Americans (AA). Given treatment advances, most individuals survive at least 5-10 years, making symptom management important. Many survivors struggle with pain, fatigue and limited physical function, all of which may be improved through lifestyle changes.

PY - 2020/5/25

Y1 - 2020/5/25

UR - https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e20558

U2 - 10.1200/JCO.2020.38.15_SUPPL.E20558

DO - 10.1200/JCO.2020.38.15_SUPPL.E20558

M3 - Article

VL - 38

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Exploring multiple myeloma survivor interest in lifestyle interventions.

Disciplines

Access to Document

Other files and links

Cite this